Portfolio Lab

BrightSpring Health Services, Inc.

  • Stock
  • Ticker BTSG
  • Nasdaq

Health care · Health care services · USA

$62.84 −1.84%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of BrightSpring Health Services, Inc. since 01/2024, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

BTSGGlobal equities (VT)

$10,000 grew to $57,127. Global equities (VT): $14,381.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −35.6% in 04/2025, measured from the peak in 01/2025. It took 3 months to get back to the old peak.

1-year return
+91.8%
Return p.a. since 01/2024
+85.6%
Volatility p.a.
50.5%
Largest decline
−35.6%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue1,8592,8783,1483,3343,5513,6143,8734,213
Gross profit339338375392413482493519
Operating income56514988108121130160
EBITDA1109390129148161172199
Net income163028567714984100
Earnings per share0.090.140.130.260.350.670.380.45
Balance sheet
Total assets5,9265,8475,9446,0496,4136,2135,9866,267
Liabilities4,2754,1564,1984,2284,5274,2233,9284,081
Equity1,6481,6871,7431,8191,8751,9792,0492,177
Cash61527014088889550718
Long-term debt2,5622,4892,4782,4652,4552,4452,1492,147
Cash flow
Operating cash flow911024910823212344204
Capital expenditure-15-18-24-16-38-22-29-22
Free cash flow7584259219410115182

Value it:DCF calculatorMultiples calculator

Annual returns

* partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
30 Oct 2026$0.45
31 Jul 2026$0.38
1 May 2026$0.67
27 Feb 2026$0.35
28 Oct 2025$0.26
1 Aug 2025$0.13
2 May 2025$0.14
6 Mar 2025$0.09
1 Nov 2024−$0.04
2 Aug 2024$0.03

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€11bn
Market cap in trading currency
$12.5bn
Enterprise value
$14.0bn
P/E
34.0
P/S
0.82
P/B
5.74
EV/Sales
0.92
EV/EBITDA
20.6
Earnings yield
2.9%
FCF yield
3.9%

Results (last four quarters)

Revenue
$15.3bn
Gross profit
$1.91bn
EBITDA
$679m
Net income
$410m
Earnings per share
$1.85
Revenue per share
$76.64
Revenue growth
+26.4%
Earnings growth
+79.3%

Profitability

Gross margin
12.5%
Operating margin
3.4%
Net margin
2.7%
Return on equity
20.5%
Return on assets
6.5%

Balance sheet and cash flow

Cash
$718m
Cash per share
$3.61
Financial debt
$2.18bn
Debt/equity %
100
Current ratio
1.62
Book value per share
$10.94
Operating cash flow
$603m
Free cash flow
$492m

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
0%
Ex-dividend date
–

Shares and trading

Shares outstanding
199m
Volume
3.31m
Avg. volume 3 months
2.44m
Relative volume
1.3

Price and technicals

Price
$62.84
1 day
−1.8%
52-week high
$72.91
52-week low
$32.76
Distance to 52-week high
−13.8%
Distance to 52-week low
+91.8%
Distance to 50-day line
+0.4%
Distance to 200-day line
+10.4%
RSI (14)
42
Volatility 1M
59.1%

Performance

1 week
−11.8%
1 month
+3.3%
3 months
+5.6%
6 months
+7.4%
YTD
+67.8%
1 year
+94.8%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has BTSG performed since 01/2024?

$10,000 grew to $57,127 by 20 Nov 2026, which is +85.6% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is BTSG?

Volatility was 50.5% per year, measured on monthly returns. The largest decline from a peak was −35.6%, with the low in 04/2025.

How does BTSG compare with a broad equity ETF?

Over the same period Global equities (VT) returned +13.8% per year at 12.3% volatility, BTSG returned +85.6% at 50.5%. The correlation of monthly returns was 0.44; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

BrightSpring Health Services, Inc. (BTSG): Return and risk